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This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).SUMMARYDespite advances in our understanding of interactions between mouse hematopoietic stem cells (HSCs) and their niche, little is
known about communication between human HSCs and the microenvironment. Using a xenotransplantation model and intravital
imaging, we demonstrate that human HSCs display distinct motile behaviors to their hematopoietic progenitor cell (HPC) counter-
parts, and the same pattern can be found between mouse HSCs and HPCs. HSCs become significantly less motile after transplan-
tation, while progenitor cells remain motile. We show that human HSCs take longer to find their niche than previously expected
and suggest that the niche be defined as the position where HSCs stop moving. Intravital imaging is the only technique to determine
where in the bone marrow stem cells stop moving, and future analyses should focus on the environment surrounding the HSC at this
point.INTRODUCTION
Coordinating the balance between hematopoietic stem cell
(HSC) quiescence and self-renewal is crucial for maintain-
ing lifelong hematopoiesis and is controlled by a complex
network of intrinsic and extrinsic signaling interactions
with the microenvironment. While our understanding of
the regulators controlling mouse hematopoietic stem/pro-
genitor cells (HSPCs) has increased (reviewed in Morrison
and Scadden, 2014), little is known about whether these
factors and cellular micro-environmental component(s)
that are important for mouse HSPCs could also be extrapo-
lated to human HSPCs. The most widely used system that
mimics the human niche in vivo is the xenotransplanta-
tion model. In this system, immunodeficient mouse bone
marrow (BM) provides efficient support of human HSPCs
allowing multilineage reconstitution. Once transplanted,
HSPCs are home to the BM where they reside in specific
niches that direct proliferation, quiescence, apoptosis,
and mobilization into the periphery. Reconstitution can
be followed by peripheral blood sampling or BM aspiration
weeks after transplantation, but the first and most critical
stages of lodgment (defined as their position at early time
points post-transplant; Lapidot et al., 2005) are not well
characterized. A recent study provided the first demonstra-
tion of the use of human-mouse xenografts as a surrogate
model to study positioning of human HSPCs in human
bone biopsy specimens, indicating that similar micro-
environmental niches could be defined in the xenotrans-
plant model (Guezguez et al., 2013). However, current
approaches visualizing stem cells and their niche in fixed
sections cannot define the true niche since the cellmay still690 Stem Cell Reports j Vol. 5 j 690–701 j November 10, 2015 j ª2015 Thehave been migrating when the tissue sample was taken.
The only way to visualize cell movements in the BM with
sufficient spatial/temporal resolution without physically
damaging the niche is by intravital imaging of the calvaria
(Lo Celso et al., 2009). While different in structure and
developmental origin to the long bones, HSCs in the
calvaria show identical HSC frequency and function to
those found in the femur (Lassailly et al., 2013; Lo Celso
et al., 2009).
Intravital imaging of mouse HSPCs in calvaria showed
that by 16 hr after transplantation, the majority of cells
had entered the bone, crossed the endothelium, and
lodged within a few cell diameters of bone. HSPCs localized
to distinct regions according to their differentiation status
(Lo Celso et al., 2009); at least in the calvaria, both osteo-
blastic and vascular niches are not physically separate,
and a cell can be located within both. However, it remains
unclear whether we can extrapolate the definition of the
mouse HSC niche to human. In order to study the early
phases of humanHSPC homing and lodgment, we adopted
a similar approach used by Lo Celso et al. (2009) to track
human andmouseHSPCs in the calvaria of livemice. Using
time-lapse imaging, we show that both human and mouse
HSCs and hematopoietic progenitor cells (HPCs) exhibit
strikingly different motile behaviors. It takes human
HSC-enriched cells longer than expected to find their niche
at which point motility decreases. In comparison, progen-
itor-enriched populations continue to navigate the micro-
environment. We show that blocking integrin binding
within the niche can reverse the relatively non-motile
phenotype of HSCs, indicating a role for integrins in the
motility of HSCs after lodgment. We also found a similarAuthors
pattern of motility in mouse HSPCs, where HSCs were
much less motile than HPCs. Our results suggest that for
human cells, the definition of lodgment should be
described by their position when cells stop moving and
that, on a whole-population level, migratory behavior
in vivo can be used to identify a more pure population of
human and mouse HSCs. Imaging of migratory behavior
is crucial in order to pinpoint the location of where stem
cells stop moving and lodge, which is indicative of the
HSC niche. Once the location is confirmed, a more thor-
ough analysis of the microenvironment at this location
can be performed. Moreover, intravital imaging can be
used to test pharmacological, antibody blocking, or genetic
manipulation of molecules thought to play a role in HSC
function since it allows one to determine whether func-
tional defects occur from an inability to migrate or adhere
during the distinct homing, lodgment, and mobilization
processes.RESULTS
Developing Tools to Track Human/Mouse HSPCs by
Intravital Microscopy
In order to visualize HSPC interactions with their niche,
cells must be labeled with a fluorescent marker. Lipophilic
dyes have been used to track HSPCs, but leakage of dye
and contamination of microenvironment is possible (Las-
sailly et al., 2010). Amine reactive cell dyes do not appear
to leak and are frequently used to track lymphocyte
division and migration (De Clerck et al., 1994; Nolte
et al., 2004). However, since CFSE and SNARF have been
reported to have some negative effects on cell function,
we performed analyses to find the optimal concentration
(carboxyfluorescein succinimidyl ester [CFSE] 2 mM and
SNARF 1.5 mM, data not shown). We confirmed non-
toxicity using in vivo transplantation experiments,
showing no detrimental effects on engraftment of dye-
labeled HSPCs in primary and secondary recipients
(Figures S1A and S1B). Furthermore, each time point and
population were repeated using both dyes in order to
ensure no effect on motility of a specific dye (Figure S1C).
The possibility of autofluorescent cells in the BM being
mistaken for dye-labeled cells is minimal since autofluores-
cent cells appear in both CFSE (green) and SNARF (red) de-
tectors and appear as yellow/orange objects (Figure S1D).
Any object that appears in both CFSE and SNARF channels
was excluded from the analysis.
In addition to visualizing stem and progenitor popula-
tions labeled with dyes, we collected the second harmonic
signal emitted by collagen in bone (cyan). The distance
from the center of the cell to the closest pixel of bone sur-
face is displayed graphically. Using this protocol, we areStem Cell Rable to track cell position relative to the bone surface and
movements over time.
Human HSC- and HPC-Enriched Populations Take up
to 4 days to Lodge in an Endosteal Niche
A recent report from Bhatia’s group showed that human
HSPCs xenotransplanted into an immunodeficient mouse
resided in both vascular and endosteal regions at steady
state, similar to indigenous HSPCs in human bone. The
report by Bhatia’s group demonstrated functional human
hematopoiesis in mice, validating the use of human-
mouse BM xenografts. However, the authors did not track
cell migration over time in order to describe homing and
lodgment (Guezguez et al., 2013). We applied a similar
xenotransplantation technique to study migration, hom-
ing, and lodgment of human HPSCs. Prior to starting these
experiments, we tested our intravital imaging technique
using mouse HSPCs to confirm expected results with those
previously published (Lo Celso et al., 2009). Likewise, we
saw that at 16 hr after transplantation mouse HSPCs
had crossed the endothelium to enter the BM and were
located with two to three cell diameters of the bone sur-
face (data not shown). To track human HSPCs, we used
expression of lineage markers (Lin), CD34 and CD38
to sort HSC-enriched LinCD34+CD38 and HPC-en-
riched LinCD34+CD38+ cells (herein referred to as +/
and +/+). We transplanted these cells into sublethally irra-
diated NSG mice. By 16-hr post-transplant, the cells have
crossed the endothelium and entered the BM cavity
(Figure 1B, top row). However, time-lapse microscopy
indicated that cells were still motile, suggesting that at
16 hr they may not be lodged in their final niche, so we
continued to track cells for up to 4 days after transplanta-
tion (Figures 1A and 1B). Serial analyses showed that
both +/ and +/+ populations continue to move and get
progressively closer to bone (Figures 1A and 1B), eventu-
ally settling at an average distance of within one to two
cell diameters (one cell diameter = 6 to 8 mm; Xie et al.,
2009) of the endosteum at day 4 (Figures 1A and 1B, bot-
tom row). It is possible that differences in position of cells
over time are due to changes in niche architecture such as
vascular remodeling or osteoblast loss following irradia-
tion. As such, a more detailed analysis of transplanted
cell position in relationship to other niche components af-
ter irradiation will be required. Another possible explana-
tion for the change in position of HSPCs is that cells
that are close to the endosteum persist, while those located
further away are lost through apoptosis and/or have prolif-
erated and thus lost their dyes. However, it is not currently
possible to measure apoptosis of cells that reside in one
location versus another in order to address this question.
Furthermore, we could not detect cells that have under-
gone proliferation.eports j Vol. 5 j 690–701 j November 10, 2015 j ª2015 The Authors 691
Figure 1. In Vivo Imaging of Human
HSPCs
CB mononuclear cells (CB MNCs) were flow
sorted to purify LinCD34+CD38 (+/)
and LinCD34+CD38+ (+/+) populations and
then labeled with dyes and injected IV in
NSG recipients.
(A) Live distance measurements in mm
of +/ and +/+ cells in the calvaria to bone
at 16 hr and days 2, 3, and 4 post-trans-
plantation.
(B) Live images from calvaria of mice
transplanted with +/ (green, left) and +/+
(red, right) cells at 16 hr (top) and day 4
(bottom) after transplantation. Second
harmonic signal generated by the bone is
cyan. Scale bars represent 50 mm. N = 9 re-
cipients of cells from pooled CB units (two
recipients for 16 hr, two recipients for day 2,
three recipients of day 3, three recipients of
day 4). Each recipient received cells from
approximately six to nine CB donors.HSCs that Home to the BM and Persist after
Transplantation Retain Stem Cell Activity
It is possible that at 4 days after transplantation the cells
that we are imaging may no longer be stem cells and
have differentiated and/or lost repopulating ability. There-
fore, the phenotype of transplanted cells we seemay not be
characteristic of stem cells. In order to determine the extent692 Stem Cell Reports j Vol. 5 j 690–701 j November 10, 2015 j ª2015 Theof transplanted cell differentiation, we retrieved the
CFSE+ cells at day 4 and performed a FACS analysis of these
cells. A high proportion of these CFSE+ cells were still
CD34+CD38, and more than 66% were CD45RACD90+,
indicating that these CFSE+ cells imaged at day 4 are still
phenotypically enriched in repopulating cells (Figure 2A).
To confirm this functionally, we compared their secondaryAuthors
Figure 2. Estimation of Stem Cell Frequency of Cells that Home
to and Persist in the BM after Transplantation
(A) FACS analysis (top) of the CSFE+ CD34+CD38 before trans-
plantation (bottom) FACS analysis of the CSFE+ cells extracted from
the BM of NSG mice at day 4 post-transplantation.
(B) (left) Protocol to assess colony-forming ability of cells visible
by microscopy; 300 LinCD34+CD38 (+/) cells were plated
directly into methylcellulose (before transplantation group) or
stained with CFSE and injected IV into NSG recipient. After homing,
mice were sacrificed; BM was extracted from femurs, tibias, and iliac
crests and re-sorted to obtain CFSE+ cells; and these were plated
into methylcellulose (after transplantation group). 75,000 cells
from primary colonies were obtained after 14 days and re-plated
to generate secondary colonies. (Right) Number of secondary
colonies. N = 5 independent experiments from pooled CB units.
Error bars represent ± SD. *p < 0.05, **p < 0.01, ***p < 0.001.
(C) (left) Protocol to assess stem cell frequency after trans-
plantation. Lineage-depleted CB MNCs were stained with Lin, CD34,
and CD38 antibodies and sorted by FACS to purify LinCD34+CD38
cells. Cells were injected intra-bone at limiting dose into suble-
thally irradiated recipients (before transplantation group) or
Stem Cell Rclonogenic capacity by colony forming unit (CFU) of the
CFSE+ cells that had been transplanted and recovered
by fluorescence-activated cell sorting (FACS) (‘‘after
transplantation’’) to fresh CFSE labeled +/ cells (‘‘before
transplantation’’) that were plated immediately into meth-
ylcellulose. After 2 weeks, the colonies were re-plated to
generate secondary colonies (Figure 2B). The group of cells
that was extracted from the mouse after transplantation
showed a 2- to 3-fold increase in secondary re-plating
ability (75,000 cells from ‘‘before transplantation’’ colonies
gave 75 colonies’ 75,000 cells from ‘‘after transplantation’’
colonies gave 181 colonies; Figure 2B). We further per-
formed an in vivo limiting dilution assay (LDA) experiment
to assess stem cell frequency in CFSE+ cells before and after
transplantation. Before transplantation and after trans-
plantation cells were injected intra-bone into the tibia of
sublethally irradiated NSG mice at doses ranging from
5 to 80 cells (Figure 2C, left). After 12 weeks, engraftment
was assessed by flow cytometry and repopulating-cell fre-
quency calculated. The engraftment frequency after trans-
plantation (frequency: 1 in 19, 95% confidence interval: 1
in 10.4 to 1 in 35.8) was statistical similar to that before
transplantation (frequency: 1 in 33.3, 95% confidence
interval: 1 in 18.7 to 1 in 59.5) (Figure 2C, right). These
analyses showed that CFSE+ cells imaged at day 4 were still
functionally enriched in cells with repopulating andmulti-
potential activity, suggesting that we are still imaging bona
fide stem-enriched cells.
HSC- and HPC-Enriched Populations Exhibit Distinct
Motility Behaviors
Since HSCs appeared to keepmoving after transplantation,
we performed live cell tracking to determine whether and/
or when the cells stopmigrating and whether there are any
dynamic differences during their homing. At 16 hr, days 2,
3, 4, and 6 after transplantation, we tracked cells for 2 to
4 hr and calculated the displacement per hour, speed, and
straightness. Displacement per hour describes the distance
between the start and end point of migration corrected
for time, which shows overall movement of the cell.stained with CFSE and injected IV into NSG recipient. After homing,
mice were sacrificed, BM was extracted from femurs, tibias, and iliac
crests and re-sorted by FACS to obtain CFSE+ cells and were injected
intra-bone into the tibia at limiting dilution in sublethally irradi-
ated recipients (after transplantation group). (Right) Engraftment
at 12 weeks was assessed by flow cytometry for human CD45 mul-
tilineage (containing CD3, CD19, and CD33 cells) engraftment and
scored positive if above 0.1%. ELDA software was used to calculate
the frequency of repopulating cells. N = 48 mice (before and after
cohort of mice used per condition: two mice each for 5, 20, and 40
cell doses, six mice each for 60 and 80 cell dose, from two inde-
pendent experiments from approximately 9–12 pooled CB units).
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Straightness is a measure of whether a cell is moving in
a straight line (directed motion) or moving randomly; a
value closer to 1 equals a straight path, while a lower value
is indicative of random walk. Displacement values showed
that 16 hr after transplantation, there were no differences
between +/ and +/+ populations (Figure 3Ai). Both popu-
lations have an elongated morphology and are highly
motile by day 3 (Figure 3Ai; Movie S1). However, by day 4
after transplantation, +/ cells dramatically decrease their
displacement and remain rounded while the majority
of +/+ cells remain highlymotile and elongated (Figure 3Ai;
Movie S2), and although there is a smaller subpopulation
that are still moving, the majority of +/ cells stay within
a few microns of their starting position. Statistical analysis
by ANOVA test showed a significant difference in displace-
ment between +/+ and +/ cells (p = 0.001) and between
time points (p = 1006) (comparing days 3 and 4). The
difference inmotility is highlighted whenmigration tracks
are displayed graphically; the tracks of +/ (green) and +/+
(red) cells show similar patterns at day 3 (Figures 3D, left,
and S2A and S2B), while the same analyses show a marked
difference in pattern at day 4 (Figures 3D, right, and S2A
and S2B). Analysis of cell speed showed a similar pattern
whereby both had a similar speed at day 3, but at day
4, +/ cells had a lower speed than +/+ cells. Statistical
analysis by ANOVA test showed a significant difference in
speed between +/+ and +/ cells (p = 1005) and between
time points (p = 1009) (comparing days 3 and 4) (Fig-
ure 3Bi). The pattern of migration was also changed signif-
icantly over days 3 and 4, with +/ cells exhibiting a more
random walk type of motility by day 4, as indicated by
lower straightness values (Figure 3Ci) (p = 1005).
Observations of cell movements indicated that +/ cells
changed their morphology between days 3 and 4 after
transplantation. In order to determine whether there was
a significant difference in cell shape, wemeasured the sphe-
ricity of HSPCs (+/ cells) when they were at their most
motile on Day 3 and at Day 4, when the majority of cells
stopped moving. These analyses showed that +/ cells at
day 3 are statistically less spherical (a value closer to 0)
and thus more polarized compared with +/ cells at
day 4, which were more spherical (a value closer to 1; Fig-
ure 3E). Together, the change in morphology combined
with a difference inmotility, as measured by displacement,
speed, and straightness, indicates a change in behavior of
the majority of the +/ population over time.
To determine whether the distinct pattern of +/
motility persists beyond 4 days, we imaged 2 days later at
day 6. Hardly any +/+ cells were observed at this later
time point, probably due to high proliferation of the cells
and dilution of the dye, or apoptosis, and are not included
in the data. On a whole population level, the +/ popula-
tionwasmoremotile at day 6 than day 4 (Figure 3Ai). How-694 Stem Cell Reports j Vol. 5 j 690–701 j November 10, 2015 j ª2015 Theever, on closer inspection, it appears that there are two
distinct subpopulations; one that remains non-motile
and now a larger population of motile cells. Indeed, further
analysis of speed and straightness parameters showed that
there was no difference in speed between days 4 and 6
(Figure 3Bi), but an increase in straightness, whereby cells
were exhibiting a more directed motion type of movement
(Figure 3Ci). In order to determine whether differences
between HSC and HPC motility were specific to human
HSPCs, we also tracked the migration of mouse HSPCs.
We FACS-sorted mouse LinSCA1+cKIT+CD48CD150+
(LSK SLAM+, HSC) and the rest of the LinSCA1+cKIT+
(LSK) cells that were not CD150+CD48 (this include
HPC1, HPC2, and MPPs following Sean Morrison’s group
definition; Oguro et al., 2013). For simplicity, herein we
call these cells (LSK SLAM, HPC). Because of high HPC
proliferation, we could only track LSK SLAM cells for
16 hr. Similar to human HSPCs, mouse HSCs exhibited
a reduced displacement and had a rounded morphology
(Figure 3Aii; Movie S3) compared with their HPC counter-
parts, whichwere highlymotile and elongated (Figure 3Aii;
Movie S4). Analysis of speed indicated a significant differ-
ence between LSK SLAM+ and LSK SLAM cells (Figure 3Bii;
Movies S3 and S4), and LSK SLAM cells exhibited a trend,
but not significant difference, toward more directed
motion pattern of motility as measured by straightness
(Figure 3Cii; Movies S3 and S4), indicating that the differ-
ences between stem and progenitor cell motility is consis-
tent between species and not specific to human cells in
the xenotransplantation setting.
Heterogeneity inMotile Behavior Is Not Accounted for
by Stem Cell Purity
As indicated in Figure 3Ai, some heterogeneity exists in the
behavior of the +/ stem cell-enriched population where
not all the +/ cells stop migrating at day 4. We hypothe-
sized thatmore highly purified stem cells would be the least
displacing, while those still highly migratory were of a
more differentiated population. To test this, we sorted
highly purified HSC populations based on expression of
Lin, CD34+, CD38, CD90+, CD45RA, CD49f+ (Notta
et al., 2011) (herein called CD49f+) and CD34+, CD38,
CD90+, CD45RA, and efflux of Rhodamine 123 (Kim
et al., 1998) (herein called +/ /+//lo). We labeled and
transplanted these cells and imaged 4 days later. There
were no differences in location between +/, CD49f+,
and +//+//lo populations (Figure S2C). Surprisingly,
however, the displacement, speed, and straightness were
also similar to +/ cells (Figures 3Aiii, 3Biii, and 3Ciii),
and there was still heterogeneity in the motility of cells.
This could be due to further heterogeneity in the CD49f+
and +//+//lo phenotypes and thus functional differ-
ences that result in a difference in migration. Alternatively,Authors
Figure 3. In Vivo Migration of Human and
Mouse HSPCs
CB MNCs were lineage depleted, stained
with antibodies, and flow sorted to purify
LinCD34+CD38 (+/) and LinCD34+CD38+
(+/+) populations. Cells were labeled and
injected IV into NSG recipients.
(A–C) The displacement per hour (A), speed
(B), and straightness (C) of (i) +/ and +/+
cells inmmin the calvaria at 16 hr and at days
2, 3, 4, and 6 post-transplantation. N = 10
recipients of cells from pooled CB units (two
recipients for 16 hr, two recipients for day 2,
three recipients of day 3, three recipients of
day 4, and one recipient of day 6). Each
recipient received cells from approximately
six to nine CB donors. (ii) BM obtained from
femurs and tibias of C57Bl/6 mice were
lineage depleted, stained with Lin, SCA1,
cKIT, CD150, and CD48 antibodies, and flow
sorted to obtain LSK SLAM+ (Lin, SCA1+,
cKIT+, CD48, CD150+) and LSK SLAM
(Lin, SCA1+, cKIT+, not CD48, CD150+).
The cells were labeled and injected IV into
NSG recipients. The displacement per hour
(A), speed (B), and straightness (C) of LSK
SLAM+ and LSK SLAM in the calvaria at 16 hr
is shown. N = 2 recipients at each time point
of cells from pooled BM from approximately
10 C57Bl/6 donor mice for each recipient.
(iii) CB MNCs were lineage depleted;
stained with CD38, CD34, CD45RA, CD90, and
CD49f antibodies (‘‘CD49f’’) or the cell dye
Rhodamine123 (+//+//lo); and flow
sorted to purify HSCs compared with HSPCs
(CD34+/CD38). Cells were labeled and in-
jected IV into NSG recipients. Displacement
per hour (A), speed (B), and straightness
(C) of cells in the calvaria at 4 days after
transplantation is shown. N = 3 recipients of
CD49f+ cells, N = 2 recipients of +//+//lo
cells, and N = 3 recipients of +/ cells of
cells from approximately six to nine pooled
CB units for each recipient. The +/ data in
this figure are the same data from Figure 3A.
(D) The actual migration tracks for all +/
(green) and +/+ cells (red) from Figure 3A
were overlaid on a 3D track plot (Wolfram
Mathmatica) for day 3 (left) and day 4
(right). Total track length is displayed
which ranges from 1–2 hr per cell.
(E) Sphericity for +/ cells at day 3 and
day 4. Data obtained from the same cells in
Figure 3A.
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Figure 4. Role of Conditioning Regimes
in the Motility Behavior of HSPCs
(A) 100,000 lineage-depleted CB MNCs
were IV injected into sublethally irradiated
NSG (3.75 Gy 24 hr prior to trans-
plantation), non-irradiated NSG, and non-
irradiated hmSCF NSG mice. At 12 weeks
after transplantation, BM from tibia, femur,
and iliac crests was obtained and stained
with human CD45 antibody and analyzed by
flow cytometry. Error bars represent ± SD.
***p < 0.001. N = 5 irradiated NSG, N = 4
non-irradiated NSG, and N = 4 non-irradi-
ated hmSCF-NSG recipients of pooled CB
units.
(B and C) CFSE-labeled FACS-sorted
LinCD34+CD38 cells were transplanted IV
into 3.75 Gy sub-lethally irradiated NSG
(3.75 Gy 24 hr prior to transplantation),
non-irradiated NSG, or hmSCF NSG mice. Data indicate displacement per hour of +/ cells in mm in calvaria at 3 (B) and 4 (C) days after
transplantation. Error bars represent ± SD. ***p < 0.001. N = 3 irradiated mice, N = 4 non-irradiated mice.it is possible the CD49f+ and +//+//lo populations are
fairly pure and, depending on the cues that the cell receives
from the environment following transplantation, have
different dynamic properties. In order to further clarify
why there is heterogeneity in terms of behavior within
even the highly enriched HSC population, it would be
necessary to assess the cell-cycle status or gene expression
profile of motile versus non-motile cells; however, it is
not currently possible to purify the two populations from
the BM based on motility. Moreover, even though the
dyes used to track cell divisions are routinely used to track
cell divisions by flow cytometry, due to differential scat-
tering of reflected light dependent on how deep in the
BM the dye-labeled cell is positioned, unfortunately, we
could not use the dye to count cell divisions by imaging
and thus correlate position with proliferation status.
Could Conditioning Regimes Account for the
Differences in HSPC Motility Observed?
Since sublethal irradiation was used to condition the mice
for transplantation, it is possible that the difference in
motility of HSPCs could be due to changes in the microen-
vironment and/or in the hematopoietic cells after condi-
tioning. To investigate this possibility, we performed
identical experiments into non-irradiated NSG and non-
irradiated NSG human membrane bound stem cell factor
(hmSCF) mice. NSG-hmSCF mice were recently reported
as an improvement to the NSG model, as these mice do
not require irradiation to permit engraftment of humanhe-
matopoietic cells (Brehm et al., 2012; Takagi et al., 2012). In
our hands, we found a significant reduction in engraft-
ment in non-irradiated NSG and NSG-hmSCF recipients
compared with irradiated mice; however, there were no dif-696 Stem Cell Reports j Vol. 5 j 690–701 j November 10, 2015 j ª2015 Theferences in engraftment between non-irradiated NSG and
non-irradiated NSG-hmSCF recipients (Figure 4A); there-
fore, the two non-irradiated groups were merged in further
analyses. We performed motility comparisons at 3 versus
4 days post-transplantation. At 3 days after transplantation,
there was no difference in the average displacement be-
tween of HSPCs between non-irradiated versus irradiated
mice (Figure 4B). At day 4 post-transplantation, HSPCs
were more motile in non-conditioned NSG and NSG-
hmSCF compared with irradiated mice (Figure 4C). How-
ever, looking more closely at the displacement values from
non-irradiated recipients at day 4 (Figure 4C), it appears
that there are two subpopulations with around half of the
cells having a similar low displacement to irradiated mice
and the remaining cells being motile. This is significant
since there is around a 50% reduction in engraftment in
non-irradiated recipients (Figure 4A).We suggest that fewer
available niches in non-irradiatedmicemight explain these
results. Thus, aroundhalf of thecells stopmoving since they
have found an empty niche and are able to contribute to
engraftment, while the remaining cells are unable to find
an empty niche and keep moving and do not receive the
cues necessary to survive and therefore do not engraft. We
nevertheless could not exclude that some microenviron-
mental changes occur between days 3 and 4 in conditioned
mice, which are responsible for this change in motility
of HPCs. Further analysis using new mouse models not
requiring conditioning to achieve comparable engraftment
levels will definitively address whether the increase in avail-
able niches correlates with an increase in less motile HSCs
(similarly to conditioning), as in these mice more niche
space is available for transplanted HSPCs due to functional
impairment of endogenous HSPCs (Cosgun et al., 2014).Authors
In order to determine whether there are any gene
changes in transplanted +/ cells between 3 and 4 days af-
ter transplantation that would account for a decrease in
motility, for example, by increased adhesion, we performed
microarray analysis on +/ and +/+ cells that had been
CFSE labeled and transplanted into sublethally irradiated
NSG mice and recovered them from the BM by FACS sort-
ing at 3 and 4 days after transplantation. However, we
did not detect any upregulation of genes mediating adhe-
sion such as integrins and cadherins at day 4 that would
explain why +/ cells stop moving (data not shown).
This is likely because the function of adhesion molecules
is not regulated at the gene transcription level and/or
that adhesionmolecule function is stable after transplanta-
tion and HSCs keepmoving until they find an empty niche
that expresses the correct receptor(s).
Disruption of Integrin Binding within the Niche 4
Days after Transplantation Reverses the HSPC-Specific
Reduction in Motility 4 Days after Transplantation
When studying the movies of HSPCs migrating (Movies S1
and S2), we saw that while moving HSPCs continually
changed shape but when stopped they remained rounded.
In order for a cell tomigrate it must polarize, which leads to
changes in cell shape. We wondered whether +/ cells
became less motile at day 4 after transplantation due to
changes in their ability to polarize. One of the key players
in cell polarization is Rac1. It was shown that deletion of
Rac1 in HSPCs inhibited their ability to form cobblestones
in vitro and the frequency of Rac1/ HSPCs that were able
to home to and be retained in vivo at the endosteal surface
was reduced (Cancelas et al., 2005). In order to determine
whether altering RAC1-mediated polarization could
change the motility of +/ cells at day 4, we used a
RAC1-GEF specific inhibitor (NSC23766) in vivo. To do
this, +/ cells were imaged 4 days after transplantation to
confirm the expected pattern of +/ immobility. After-
ward, NSC23766 was injected and imaging was continued
for up to 4-hr post-injection. Surprisingly, there was no
increase in displacement (Figure 5A), speed (Figure 5B), or
straightness (Figure 5C) of +/ cells, and their position rela-
tive to the bone surface did not change (Figure 5D). How-
ever, there was a highly significant decrease in sphericity
indicating that RAC1 treatment does affect polarization
of +/ cells (Figure 5E). Thus, it appears that inhibiting po-
larization is not sufficient to change migration, and there
are other molecules that affect motility, for instance adhe-
sion molecules retain, or anchor, HSPCs in their niche.
One of the most extensively characterized signaling
pathways in HSC homing is the CXCR4/SDF1 axis.
CXCL12 binding to CXCR4 enhances the affinity of integ-
rins, in particular VLA-4, which mediates HSC cell adhe-
sion in the niche (Hartmann et al., 2008; Peled et al.,Stem Cell R1999a, 2000). Impairment of integrin or CXCR4/SDF1
expression or neutralization of their function by antibody
treatment is known to be associated with reduced HSC
homing (Kollet et al., 2001; Peled et al., 1999b; Qian
et al., 2006; Wagers et al., 2002). Treatment with the
CXCR4 receptor antagonist, AMD3100, is a potent mobi-
lizing agent (Broxmeyer et al., 2005; Liles et al., 2003),
and inhibition of VLA-4 (via Bio5192, a small molecule
inhibitor) alone and in combination with CXCR4
antagonists was shown to mobilize long-term HSPCs to
the periphery more effectively than with AMD3100 alone
(Bonig et al., 2009; Ramirez et al., 2009; Leone et al.,
2003). However, the precise role of integrin(s) in the pro-
cesses of extravasation from blood vessels into the BM
niche versus their function in migration and lodgment in
the niche is difficult to separate. In order to examine the
role of VLA-4 specifically in the migration and lodgment
of HSCs at day 4, we transplanted CFSE labeled cells in vivo.
At 4 days later, cells were imaged to confirm the expected
lack of migration of +/ cells and continued movement
of +/+ cells. We then injected VLA-4 inhibitor (Bio 5192)
and continued to track migration up to 4 hr after injection.
Addition of Bio 5192 resulted in a significant increase in
displacement (Figure 5F; Movie S5) and straightness (Fig-
ure 5H; Movie S5), a trend of, although not significant,
increased distance to the bone surface (Figure 5I) and a sig-
nificant decrease in sphericity (Figure 5J), indicating a role
for VLA-4 in the non-motile phenotype of stem cells 4 days
after transplantation. However, there was a subpopulation
of cells that did not respond to this inhibition and re-
mained relatively non-motile; thus, it is likely that other
integrins also regulate HSPC adhesion in the niche. Since
CXCR4/SDF1 might regulate the affinity of various integ-
rins in addition to VLA-4, we treated cells with the
CXCR4 antagonist, AMD3100. Similar to beta1 inhibition,
AMD3100 treatment significantly increased the displace-
ment (Figure 5F; Movie S6), speed (Figure 5G; Movie S6)
and trend, but not significant, increase in straightness (Fig-
ure 5H;Movie S6) of themajority of +/ cells, their distance
from the bone surface (Figure 5I), and significantly
decreased sphericity of the cells (Figure 5J), although again
there was still a subpopulation of cells that did not respond
to treatment. It is likely that adhesion and retention in the
niche are controlled by a complex array of adhesion mole-
cules, extracellular matrix components, and that retention
to specific stromal cell subtypes involves different mole-
cules that are yet to be defined.DISCUSSION
The location and composition of the HSCniche are areas of
intense debate in the stem cell field with numerous studieseports j Vol. 5 j 690–701 j November 10, 2015 j ª2015 The Authors 697
Figure 5. In Vivo Blocking of Integrins Reverses the Non-motile Phenotype of HSPCs
(A–E) In vivo treatment at day 4 post-transplantation of NSG mice with RAC1-GEF inhibitor NSC 23776 (3 mg/kg). Displacement (A), Speed
(B), Straightness, (C) Distance to Bone, (D) and Sphericity (E) were measured from cells imaged in the calvaria, calculated before and after
treatment. N = 2 recipients of six to nine pooled CB units for each recipient.
(F–J) In vivo treatment at day 4 post-transplantation of NSG mice with beta1 inhibitor-Bio 5192 (1 mg/kg) or CXCR4 antagonist-AMD3100
(1mg/kg). Displacement (F), speed (G), straightness (H), distance to bone (I), and sphericity (J) were measured from cells imaged in the
calvaria and were calculated before and after treatment. N = 2 recipients (AMD3100) and 3 recipients (Bio 5192) of six to nine pooled CB
units for each recipient. Error bars represent ± SD. **p < 0.01, *** p< 0.001; ****p < 0.0001.describing the niche in the mouse (Ellis et al., 2011; Kiel
et al., 2005; Nombela-Arrieta et al., 2013; Zhang et al.,
2003; Sugiyama et al., 2006; Me´ndez-Ferrer et al., 2010;
Calvi et al., 2003), human trephine sections (Guezguez
et al., 2013), and zebrafish (Tamplin et al., 2015). However,
although a recent publication described changes in
motility of HSPC in the context of parasitic infection (Ra-
shidi et al., 2014), there is very little published information
regarding the dynamics of HSPC migration in vivo and
how this correlates with functionality. Dr. Nilsson’s group
reported that just 5 hr after mouse HSC transplantation,
these cells can be further enriched functionally by extract-
ing them from the endosteal region compared to the cen-
tral bone region (Grassinger et al., 2010), demonstrating
that phenotypically identical HSCs isolated from different
regions of the BM had different biological potential. Our
data add further information on the dynamic behavior of
HSPCs by tracking human andmouse HSC and HPC popu-698 Stem Cell Reports j Vol. 5 j 690–701 j November 10, 2015 j ª2015 Thelations in vivo and showing that there are significant
differences in their motility. Specifically, we saw that
HSCs exhibit a change in motility after transplantation to
become less motile, whereas most HPCs remain motile.
This could be due to a cell-intrinsic effect where cells are
programmed to be less motile or due to cell extrinsic cues
from the microenvironment that direct the cells to stop
migrating. The probability of an HSC encountering the
correct extrinsic signal increases over time, which may ac-
count for the length of time for the population as a whole
to stop moving and why there are some non-motile cells at
earlier time points. The motility data obtained 3 days after
transplantation indicate that HSCs are capable of displac-
ing equally as well as HPCs. Therefore, the latter suggestion
is more likely, and once an HSC has found an empty niche
that expresses the correct receptor/ligand pair, it adheres
and is anchored at that position. Pharmacological block-
ing with inhibitors of VLA-4 and CXCR4 reversed theAuthors
non-motile phenotype of +/ cells, indicating that the
anchor may be VLA-4, and other, integrins dependent.
Interestingly, our results demonstrate that the dynamic be-
haviors that distinguish HSCs from HPCs are consistent in
both mouse and human, indicating that motility behavior
may be a way to discriminate between stem and progenitor
cells. The differences inmotility between stem and progen-
itor populations could be explained by differences in niche
requirements between stem and progenitor cells; stem cells
are dependent on the niche for survival, quiescence, and
proliferation, while progenitors do not require the same
niche interactions, if any, for their function.
Conventionally, the location of transplanted cells 16 hr
after transplantation is used to describe the homing niche
for HSPCs (Lapidot et al., 2005). However, the data pre-
sented here suggest that the position of HSCs at 16 hr after
transplantation cannot be used to define the niche since
cells are still migrating. Therefore, we suggest that lodg-
ment of human HSCs be defined as their position when
they stop moving. The only method to determine when a
cell has stopped migrating is by intravital imaging of live,
intact BM. At present, this is only possible in the calvaria.
As previously reported,mouseHSCs in the skull and femurs
are present at similar frequencies and are functionally iden-
tical (Lassailly et al., 2013), indicating the presence of a
functional HSC niche in the calvaria. Since HSCs have
not yet been imaged live in the long bones without first
damaging the niche architecture (Ko¨hler et al., 2009; Lew-
andowski et al., 2010; Xie et al., 2009) or at high resolution
(Branchini et al., 2010) the calvaria represents the only BM
cavity, which can be imaged non-invasively and with suffi-
cient resolution to track single-cell migration and prolifer-
ation at this time. As indicated in our time-lapse imaging,
HSCs continue to migrate after transplantation, and as
such, it is difficult to pinpoint the location of the stem
cell niche. The data show that one needs to answer ques-
tions regarding HSC homing and lodgment using multiple
approaches, including live tracking analyses to determine
when stem cells stop moving and the position of the cells
to define where in the niche they lodge. Observing the
effect on location and motility after targeting specific stro-
mal cell populations and/or niche-hematopoietic signaling
pathways should help further characterize the human HSC
niche.EXPERIMENTAL PROCEDURES
Labeling, Transplantation, and Imaging of HSC/HPCs
for Tracking
Human HSPCs were obtained from cord blood (CB) and mouse
HSPCs obtained from C57BL/6 BM. For further details on human
and mouse HSPC purification, labeling, and transplantation,
please see Supplemental Experimental Procedures.Stem Cell RRAC1, Beta1 Inhibition, and CXCR4 Antagonism of
HSC Motility
To determine the effect of inhibitors on cell migration, +/ cells
were transplanted into sublethally irradiated NSG recipients. At
4 days after transplantation, cells were imaged by intravital micro-
scopy. After 2 to 3 hr of imaging, NSC 23766 (3 mg/kg, Sigma), Bio
5192 (1 mg/kg, Tocris), or AMD3100 (1 mg/kg, Sigma) were in-
jected IV into the mouse, and imaging was resumed 30 min later
for up to 4-hr post-injection.
Image Analysis and Cell Tracking
Each z stack of images is rendered in 3D using Imaris software
(Bitplane). To correct for drift or breathing artifacts, a spot is
defined that does not move, and all time points are corrected to
this spot. An iso-surface is generated for bone, and spot function
is used to find a cell(s) of interest. The distance between center of
the cell and closest pixel of bone surface is calculated using Imaris
XTextension (Bitplane), and results are entered into Prism (Graph-
Pad Software). The mean is highlighted with a red horizontal line,
and error bars represent ± SD. The Shapiro-Wilk test was performed
to assess normality of raw and log-transformed data. Two-way
ANOVA with interaction term was performed to assess differences
between groupings where two variables (phenotype and time
point) exist. In experiments that compared one variable, t test
was used to compare differences. Statistical analyses were per-
formed using R 3.0.2.
To calculate displacement, the distance between the start and
end point of each migration track in a straight line was calculated.
Each track was corrected by time to give displacement per hour.
Displacement in a straight line from start and end points was
used in preference to track length because a cell moving randomly
with no overall movement can have the same track length as a cell
moving over a larger distance in a straight line. In-built algorithms
generate speed and straightness measurements. Straightness
describes whether the cell moves in a straight line (a value close
to 1) or in a random direction (a value close to 0). Actual migration
tracks were generated by the ‘‘Tube Plot’’ algorithm in MatLab
(Wolfram Mathmatica).
Sphericity was calculated bymeasuring the area and perimeter of
a single section through the center of a cell using this equation:
x= ð43Area3pÞ=ðPerimeter 2^Þ:
Further information can be found in Supplemental Experi-
mental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, Figures S1 and S2, andMovies S1–S6 and can be found
with this article online at http://dx.doi.org/10.1016/j.stemcr.2015.
09.003.
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